Economic Considerations Of The Veress Needle in Medical Resource Allocation

https://en.wikipedia.org/wiki/Veress_needle

Against the backdrop of increasingly strained global healthcare resources and mounting cost-containment pressures, the selection of every medical technology and device is not merely a clinical issue, but fundamentally an economic one. The Veress needle, as an entry-level consumable for laparoscopic surgery, likewise faces a trade-off between cost and effectiveness.

I. Disposable vs. Reusable: Divergent Cost Structures

Currently, Veress needles on the market are divided into two main categories: disposable and reusable.

• Disposable Veress Needles:​ Pre-sterilized and ready-to-use out of the package, these are discarded immediately after use. Their advantages include convenience, speed, elimination of cross-infection risks, and consistently optimal sharpness. The disadvantage is a higher per-procedure cost and the generation of substantial medical waste.
• Reusable Veress Needles:​ Constructed from high-quality stainless steel, these can be used dozens of times after cleaning, disinfection, and sterilization. Their advantage is a significantly lower per-use cost and environmental friendliness. However, they require investment in specialized cleaning and sterilization equipment and personnel, and performance degrades with use (dulling of the tip, spring fatigue), posing a risk of functional failure.

II. Hidden Costs: The Economic Toll of Complications

When selecting a Veress needle, the purchasing price alone cannot be the focus. The subsequent treatment costs arising from a severe complication (such as bowel perforation or major vascular injury) due to a failed insertion-including reoperation, ICU monitoring, extended hospitalization, and potential litigation-would be astronomical, dwarfing any price difference between needle models.

Therefore, from a health economics perspective, choosing a Veress needle with a reliable design and stable quality, even at a slightly higher unit price, may prove "cost-effective" by mitigating complication risks. Conversely, opting for an inferior product to save a few dollars is akin to a high-risk gamble.

III. Macro Perspective: The Leverage Effect of Promoting Minimally Invasive Surgery

From a broader perspective, the application of the Veress needle drives the adoption of laparoscopic surgery. Compared to traditional open surgery, laparoscopy increases certain consumable costs (including the Veress needle, trocars, staplers, etc.). However, by shortening hospital stays, reducing post-operative medication, and accelerating the patient's return to the workforce, it creates significant indirect economic benefits for society.

A cost-benefit analysis of laparoscopic cholecystectomy shows that although the direct surgical cost is higher than that of open surgery, the total social cost is lower when factoring in the reduced number of lost workdays due to faster recovery. The Veress needle, as the "key" that initiates the entire minimally invasive workflow, plays an indispensable role in this equation.

IV. Future Directions: Balancing Intelligence with Cost-Effectiveness

In the future, with advancements in sensor technology and the Internet of Things (IoT), smarter "disposable + data" Veress needles may emerge. These devices will not only perform the puncture but also record biomechanical data during insertion, providing surgeons with performance feedback and objective evidence for medical disputes. While the unit cost of such products may be higher, their added value-enhancing safety, improving training quality, and reducing legal risk-may result in superior overall cost-effectiveness.

Conclusion

For healthcare institutions, selecting a Veress needle should not be a simple binary choice between "expensive or cheap." Rather, it requires a comprehensive cost-benefit analysis based on multiple factors: surgical volume, patient demographics, hospital infection control standards, and surgeon skill levels. Only then can an optimal resource allocation decision be made.